BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7838962)

  • 21. Late functional response of mouse urinary bladder to fractionated X-irradiation.
    Dörr W; Bentzen SM
    Int J Radiat Biol; 1999 Oct; 75(10):1307-15. PubMed ID: 10549608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiation induced late damage to the barrier function of small blood vessels in mouse bladder.
    Jaal J; Dörr W
    J Urol; 2006 Dec; 176(6 Pt 1):2696-700. PubMed ID: 17085198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Compensation for changes in dose-rate in radical low-dose-rate brachytherapy: a radiobiological analysis of a randomised clinical trial.
    Roberts SA; Hendry JH; Swindell R; Wilkinson JM; Hunter RD
    Radiother Oncol; 2004 Jan; 70(1):63-74. PubMed ID: 15036854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate.
    Luxton G; Hancock SL; Boyer AL
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):267-84. PubMed ID: 15093924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiation hepatology of the rat: time-dependent recovery.
    Geraci JP; Mariano MS; Jackson KL
    Radiat Res; 1993 Nov; 136(2):214-21. PubMed ID: 8248478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amelioration of early radiation effects in oral mucosa (mouse) by intravenous or subcutaneous administration of amifostine.
    Fleischer G; Dörr W
    Strahlenther Onkol; 2006 Oct; 182(10):567-75. PubMed ID: 17013569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on the red marrow dosimetry in radioimmunotherapy: an experimental investigation of factors influencing the radiation-induced myelotoxicity in therapy with beta-, Auger/conversion electron-, or alpha-emitters.
    Behr TM; Sgouros G; Stabin MG; Béhé M; Angerstein C; Blumenthal RD; Apostolidis C; Molinet R; Sharkey RM; Koch L; Goldenberg DM; Becker W
    Clin Cancer Res; 1999 Oct; 5(10 Suppl):3031s-3043s. PubMed ID: 10541340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute changes in the bladder reservoir function after irradiation alone or in combination with chemotherapy: a matter of mouse strain.
    Lundbeck F; Stewart FA
    Scand J Urol Nephrol Suppl; 1989; 125():141-7. PubMed ID: 2633312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose-survival curves, alpha/beta ratios, RBE values, and equal effect per fraction for neutron irradiation of jejunal crypt cells.
    Withers HR; Mason KA; Taylor JM; Kim DK; Smathers JB
    Radiat Res; 1993 Jun; 134(3):295-300. PubMed ID: 8316621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recovery from sublethal damage during fractionated irradiation of human FaDu SCC.
    Petersen C; Zips D; Krause M; Völkel W; Thames HD; Baumann M
    Radiother Oncol; 2005 Mar; 74(3):331-6. PubMed ID: 15763315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The response of mouse skin to fractionated doses of fast neutrons (66 MeVp-Be) with variable interfraction and overall treatment times.
    Blekkenhorst G; Jones D; Duffett R; Hendrikse A; Hunter A
    Strahlenther Onkol; 1995 Jan; 171(1):42-8. PubMed ID: 7839304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanical assay of consequential and primary late radiation effects in murine small intestine: alpha/beta analysis.
    Peck JW; Gibbs FA
    Radiat Res; 1994 May; 138(2):272-81. PubMed ID: 8183998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Morphological changes in the bladder of female mice after x-ray and peak-pion irradiation (the piotron)].
    Meier-Göhr D
    Strahlenther Onkol; 1989 Aug; 165(8):622-6. PubMed ID: 2772820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiation administered as a large single dose or in a fractionated schedule: Role of the tumour vasculature as a target for influencing response.
    Horsman MR; Nielsen T; Østergaard L; Overgaard J
    Acta Oncol; 2006; 45(7):876-80. PubMed ID: 16982553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of very low dose-rate (90)Sr/(90)Y exposure on the acute moist desquamation response of pig skin.
    Millar WT; Hopewell JW
    Radiother Oncol; 2007 May; 83(2):187-95. PubMed ID: 17467835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
    Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
    Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of systemic or topical administration of sodium selenite on early radiation effects in mouse oral mucosa.
    Gehrisch A; Dörr W
    Strahlenther Onkol; 2007 Jan; 183(1):36-42. PubMed ID: 17225944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different immobilization procedures during irradiation influence the estimation of alpha/beta ratios in mouse lip mucosa.
    Stüben G; Landuyt W; van der Schueren E; van der Kogel AJ
    Strahlenther Onkol; 1993 Nov; 169(11):678-83. PubMed ID: 8248845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recovery from sublethal damage during intermittent exposures in cultured tumor cells: implications for dose modification in radiosurgery and IMRT.
    Shibamoto Y; Ito M; Sugie C; Ogino H; Hara M
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1484-90. PubMed ID: 15275736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.